×
Phibro Animal Health Inventory 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phibro Animal Health inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Phibro Animal Health Inventory 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phibro Animal Health inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$203.2B
Stryker (SYK)
$148.2B
Boston Scientific (BSX)
$133.1B
EssilorLuxottica (ESLOY)
$113.5B
Medtronic (MDT)
$109B
Haleon (HLN)
$42.9B
Lonza Group Ag (LZAGY)
$42.1B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35B
Terumo (TRUMY)
$29.2B
Koninklijke Philips (PHG)
$24.4B
Zimmer Biomet Holdings (ZBH)
$22.1B
Insulet (PODD)
$18.4B
Baxter (BAX)
$16.6B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$9B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$5.5B
TG Therapeutics (TGTX)
$4.7B
Haemonetics (HAE)
$4.3B
ICU Medical (ICUI)
$4.2B
Prestige Consumer Healthcare (PBH)
$4.1B
Perrigo (PRGO)
$3.7B
Envista Holdings (NVST)
$3.5B
Neogen (NEOG)
$3.3B
Agios Pharmaceuticals (AGIO)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.6B